Vanda Pharmaceuticals Inc.
METHOD OF TREATMENT WITH TRADIPITANT

Last updated:

Abstract:

Methods of treating an individual experiencing or at risk of experiencing an undesired consequence of opioid use, and of treating an individual who is experiencing or at risk of experiencing a craving for an opioid, as well as the use of the NK-1 receptor antagonist, tradipitant, in the treatment of such an individual are disclosed herein.

Status:
Application
Type:

Utility

Filling date:

6 Jun 2019

Issue date:

29 Jul 2021